FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / DELIVERY ORDER

NIH NHLBI CARDIOVASCULAR BRANCH REQUIRES CYTATION 1 READER IN ORDER TO COMPLETE CLINICAL AND RESEARCH EXPERIMENTS IN THE DIR

Awarded to BIOTEK INSTRUMENTS, INC.

PIID 75N92021F00230US · USAspendingResearch & Science
$35.6K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$35,634sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateAug 17, 2021
Company legal name
BIOTEK INSTRUMENTS, INC.
UEI / CAGE
C46JMK5M9N23 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Research & Science
NAICS
334516
PSC
6515
Performance period
Not reported — Not reported
Recipient address
100 TIGAN ST, WINOOSKI, CHITTENDEN, VT, 05404
Place of performance
WINOOSKI, CHITTENDEN, VT, 05404
Source last modified
Nov 3, 2026

Description

NIH NHLBI CARDIOVASCULAR BRANCH REQUIRES CYTATION 1 READER IN ORDER TO COMPLETE CLINICAL AND RESEARCH EXPERIMENTS IN THE DIR

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    NIH NHLBI CARDIOVASCULAR BRANCH REQUIRES CYTATION 1 READER IN ORDER TO COMPLETE CLINICAL AND RESEARCH EXPERIMENTS IN THE DIR

    US · usaspendingSource ↗
  2. Value increased

    NIH NHLBI CARDIOVASCULAR BRANCH REQUIRES CYTATION 1 READER IN ORDER TO COMPLETE CLINICAL AND RESEARCH EXPERIMENTS IN THE DIR

    US · usaspending$35.6KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Aug 17, 20210Not reported$35,634.30Not reportedNot reportedNIH NHLBI CARDIOVASCULAR BRANCH REQUIRES CYTATION 1 READER IN ORDER TO COMPLETE CLINICAL AND RESEARCH EXPERIMENTS IN THE DIRUSAspending ↗